Human cytomegalovirus-IgM seropositivity is not associated with atherogenic alterations of lipid profiles and inflammatory status in ischemic stroke patients: A preliminary study

Neurological Research

Volumn 33, Issue 5, 2011, Pages 473-481

  Liu, Lei ^a,b   Tuo, Hou Zhen ^a,b   Wang, Rui Jin ^a,b   Yi, Li ^a,b   Wang, Jia Wei ^a,b   Wang, De Xin ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute ischemic stroke; High sensitivity C reactive protein; Human cytomegalovirus igm; Metabolic disorders; Plaque instability

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CYTOMEGALOVIRUS; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BRAIN ISCHEMIA; COHORT STUDIES; COMORBIDITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMMUNOGLOBULIN M; INFLAMMATION; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; PILOT PROJECTS; STROKE; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 79958727945     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164111X13007856084007     Document Type: Article

References (42)

1. Hsich E, Zhou YF, Paigen B, Johnson TM, Burnett MS, Epstein SE, et al. Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice. Atherosclerosis 2001;156:23-8.
2. Melnick JL, Petrie BL, Dreesman GR, McCollum CH, Petrie BL, Burek J, et al. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983;2:644-7.
3. Shi Y, Tokunaga O. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 2002;52:31-9.
4. Yi L, Lin JY, Gao Y, Feng ZJ, Wang DX. Detection of human cytomegalovirus in the atherosclerotic cerebral arteries in han population in China. Acta Virol 2008;52:99-106.
5. Ibrahim AI, Obeid MT, Jouma MJ, Moasis GA, Al-Richane WL, Kindermann I, et al. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol 2005;32:29-32.
6. Abdalla Abbas M, Guenther A, Galantucci S, Fawi G, Comi G, Kwan J, et al. Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options. Open Neurol J 2008;2:20-4.
7. Elkind MS, Luna JM, Moon YP, Boden-Albala B, Liu KM, Spitalnik S. Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke 2010;41:e117-22.
8. Roberts ET, Haan MN, Dowd JB, Aiello AE. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol 2010;172:363-71.
9. Blum A, Peleg A, Weinberg M. Anti-cytomegalovirus (CMV) IgG antibody titer in patients with risk factors to atherosclerosis. Clin Exp Med 2003;3:157-60.
10. Eryol NK, Kiliç H,Gül A, Ozdogru I, Inanc T, Dogan A,et-al. Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease? Int Heart J 2005;2:205-9.
11. Cheng J, Ke Q, Jin Z, Wang H, Kocher O, Morgan JP, et al. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog 2009;5:e1000427.
12. Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992;41(Suppl. 2):97-101.
13. Froberg MK, Adams A, Seacotte N, Dahlberg E. Cytomegalovirus seropositivity and serum total cholesterol levels in young patients. Ann Clin Lab Sci 2001;31:157-61.
14. Szkaradkiewicz A, Bogaczyńska-Staniewicz J, Torliński L, Wal M. Cytomegalovirus infection and atherogenesis. Med Sci Monit 2002;8:CR104-7.
15. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 1999;34:1738-43.
16. Kaftan HA, Kaftan O, Kilic M. Markers of chronic infection and inflammation. Are they important in cases with chronic coronary heart disease? Jpn Heart J 1999 40: 275-80.
17. Bouwman JJ, Visseren FL, Bosch MC, Bouter KP, Diepersloot RJ. Procoagulant and inflammatory response of virus-infected monocytes. Eur J Clin Invest 2002;32:759-66.
18. Borgia MC, Mandolini C, Barresi C, Battisti G, Carletti F, Capobianchi MR. Further evidence against the implication of active cytomegalovirus infection in vascular atherosclerotic diseases. Atherosclerosis 2001;157:457-462.
19. Yonemitsu Y, Kaneola Y, Komori K, Hirai K, Sugimachi K, Sueishi K. The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cells proliferation in vivo and in vitro. Biochem Biophys Res Commun 1997;231:447-51.
20. Sambiase NV, Higuchi ML, Nuovo G, Gutierrez PS, Fiorelli AI, Uip DE, et al. CMV and transplant related coronary atherosclerosis: an immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study. Mod Pathol 2000;13:173-9.
21. Kol A, Sperti G, Shani J, Schulhoff N, van de Greef W, Landini MP, et al. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 1995;91:1910-3.
22. Ozbay Y, Akbulut M, Balin M, Kayancicek H, Baydas A, Korkmaz H. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment. Mediators Inflamm 2007;2007:89649.
23. Hsu CW, Lin JL, Tan LD, Yen TH, Chen KH. White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients. Ther Apher Dial 2010;14:552-9.
24. Fang L, Wei H, Mak KH, Xiong Z, Song J, Wang D, et al. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease. Can J Cardiol 2004;20:1433-8.
25. Kato A, Takita T, Furuhashi M, Maruyama Y, Kumagai H, Hishida A. Blood monocyte count is a predictor of total and cardiovascular mortality in hemodialysis patients. Nephron Clin Pract 2008;110:c235-43.
26. Unek IT, Bayraktar F, Solmaz D, Ellidokuz H, Yuksel F, Sisman AR, et al. Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome. Metabolism 2010;59:305-13.
27. Sun JY, Zhao D, Wang W, Liu J, Cheng J, Liu J, et al. Distributions of high-sensitivity C-reactive protein and its association with metabolic syndrome in population aged 45-74 in Beijing. Zhonghua Liu Xing Bing Xue Za Zhi 2007;28:1155-8.
28. Souza MA, Passos AM, Treitinger A, Spada C. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil. Rev Soc Bras Med Trop 2010;43:359-361.
29. Bonon SH, Rossi CL, de Souza CA, Vigorito AC, Costa SC. Comparison of serology, antigenemia assay and the polymerase chain reaction for monitoring active cytomegalovirus infections in hematopoietic stem cell transplantation patients. Rev Inst Med Trop Sao Paulo 2006;48:275-8.
30. Connor MD, Lammie GA, Bell JE, Warlow CP, Simmonds P, Brettle RD. Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke 2000;31:2117-26.
31. Ortiz G, Koch S, Romano JG, Forteza AM, Rabinstein AA. Mechanisms of ischemic stroke in HIV-infected patients. Neurology 2007;68:1257-61.
32. Connor M. Human immunodeficiency virus (HIV) and stroke: targets for intervention. Infect Disord Drug Targets 2010;10:76-83.
33. Lentine KL, Rocca Rey LA, Kolli S, Bacchi G, Schnitzler MA, Abbott KC, et al. Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol 2008;3:1090-101.
34. Al Ghamdi G, Awada A, Tanimu DZ, Huraib SO, Abu Romeh S, Quadri K, et al. Neurological disorders in renal transplant recipients. Saudi J Kidney Dis Transpl 1998;9:435-9.
35. Oliveras A, Roquer J, Puig JM, Rodriguez A, Mir M, Orfila MA, et al. Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome. Clin Transplant 2003;17:1-8.
36. Kamano C, Komaba Y, Sakayori O, Iino Y, Katayama Y. Decreased cerebral blood flow in renal transplant recipients. Intern Med 2002;41:677-83.
37. Ozsoyhi S, Strauss HS, Diamond LK. Effects of corticosteroids on coagulation of the blood. Nature 1962;195:1214-5.
38. Aull-Watschinger S, Konstantin H, Demetriou D, Schillinger M, Habicht A, Hörl WH, et al. Pre-transplant predictors ofcerebrovascular events after kidney transplantation. Nephrol Dial Transplant 2008;23:1429-35.
39. Abramson JL, Jurkovitz CT, Vacarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia and incident stroke in a middle aged community based population: the ARIC Study. Kidney Int 2003;64:610-5.
40. Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S, et al Stroke in patients in maintenance hemodialysis 22 year single-center study. Am J Kidney Dis 2005;45:1058-66.
41. Krishna PR, Naresh S, KrishnaGS, Lakshmi AY, Vengamma B, Kumar VS. Stroke in chronic kidney disease. Indian J Nephrol 2009;19:5-7.
42. Seliger S, Gillen D, Kestenbaum B, Ball A, Wasse H, Stehman-Breen C. A comparison of stroke rates among the dialysis and general populations. J Am Soc Nephrol 2002;13:438A.